JP2020527335A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527335A5
JP2020527335A5 JP2019569784A JP2019569784A JP2020527335A5 JP 2020527335 A5 JP2020527335 A5 JP 2020527335A5 JP 2019569784 A JP2019569784 A JP 2019569784A JP 2019569784 A JP2019569784 A JP 2019569784A JP 2020527335 A5 JP2020527335 A5 JP 2020527335A5
Authority
JP
Japan
Prior art keywords
promoter
aav
sequence
seq
vector according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019569784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527335A (ja
JP7766393B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/037592 external-priority patent/WO2018232149A1/en
Publication of JP2020527335A publication Critical patent/JP2020527335A/ja
Publication of JP2020527335A5 publication Critical patent/JP2020527335A5/ja
Priority to JP2023098376A priority Critical patent/JP2023116709A/ja
Application granted granted Critical
Publication of JP7766393B2 publication Critical patent/JP7766393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019569784A 2017-06-14 2018-06-14 眼疾患のための遺伝子療法 Active JP7766393B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023098376A JP2023116709A (ja) 2017-06-14 2023-06-15 眼疾患のための遺伝子療法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762519821P 2017-06-14 2017-06-14
US62/519,821 2017-06-14
PCT/US2018/037592 WO2018232149A1 (en) 2017-06-14 2018-06-14 Gene therapy for ocular disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023098376A Division JP2023116709A (ja) 2017-06-14 2023-06-15 眼疾患のための遺伝子療法

Publications (3)

Publication Number Publication Date
JP2020527335A JP2020527335A (ja) 2020-09-10
JP2020527335A5 true JP2020527335A5 (enExample) 2021-07-26
JP7766393B2 JP7766393B2 (ja) 2025-11-10

Family

ID=64660849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019569784A Active JP7766393B2 (ja) 2017-06-14 2018-06-14 眼疾患のための遺伝子療法
JP2023098376A Pending JP2023116709A (ja) 2017-06-14 2023-06-15 眼疾患のための遺伝子療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023098376A Pending JP2023116709A (ja) 2017-06-14 2023-06-15 眼疾患のための遺伝子療法

Country Status (4)

Country Link
US (1) US11827898B2 (enExample)
EP (1) EP3638316A4 (enExample)
JP (2) JP7766393B2 (enExample)
WO (1) WO2018232149A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3638316A4 (en) * 2017-06-14 2021-03-24 The Trustees Of The University Of Pennsylvania GENE THERAPY FOR EYE DISEASES
US20220143217A1 (en) * 2019-03-04 2022-05-12 The Trustees Of The University Of Pennsylvania Neuroprotective gene therapy targeting the akt pathway
CN116806158A (zh) 2020-09-02 2023-09-26 4D分子治疗有限公司 密码子优化的rep1基因及其用途
EP4284335A1 (en) 2021-02-01 2023-12-06 RegenxBio Inc. Gene therapy for neuronal ceroid lipofuscinoses
CN113322281B (zh) * 2021-05-12 2024-01-05 成都金唯科生物科技有限公司 一种高效组织特异性表达rs1蛋白的重组腺相关病毒及应用
CA3257440A1 (en) * 2022-07-06 2024-01-11 Adverum Biotechnologies Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACHROMOTOPSY
CN116411024A (zh) * 2023-03-10 2023-07-11 上海泰昶生物技术有限公司 用于生产重组腺相关病毒的质粒系统

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US5741683A (en) 1995-06-07 1998-04-21 The Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
DE69824859T2 (de) 1997-04-14 2005-08-04 Cell Genesys, Inc., Foster City Methoden zur erhöhung der effizienz rekombinanter aav produkte
US6146874A (en) 1998-05-27 2000-11-14 University Of Florida Method of preparing recombinant adeno-associated virus compositions
AU780231B2 (en) 1998-11-10 2005-03-10 University Of North Carolina At Chapel Hill, The Virus vectors and methods of making and administering the same
DE60039766D1 (de) 1999-08-09 2008-09-18 Targeted Genetics Corp Terologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
EP1409677A2 (en) 2001-01-19 2004-04-21 Incyte Genomics, Inc. Receptors and membrane-associated proteins
EP1381276A4 (en) * 2001-04-13 2005-02-02 Univ Pennsylvania METHOD FOR TREATMENT OR DEVELOPMENT SLUDGE DEGRADATION
CA2915124C (en) 2001-11-13 2018-08-14 The Trustees Of The University Of Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
ES2602352T3 (es) 2001-12-17 2017-02-20 The Trustees Of The University Of Pennsylvania Secuencias de serotipo 8 de virus adenoasociado (VAA), vectores que las contienen y usos de las mismas
WO2003104413A2 (en) 2002-06-05 2003-12-18 University Of Florida Production of pseudotyped recombinant aav virions
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
EP2298926A1 (en) 2003-09-30 2011-03-23 The Trustees of The University of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
EP2357010B1 (en) 2005-04-07 2013-06-12 The Trustees of The University of Pennsylvania Method of increasing the function of an AAV vector
US7456683B2 (en) 2005-06-09 2008-11-25 Panasonic Corporation Amplitude error compensating device and quadrature skew error compensating device
EP2007795B1 (en) 2006-03-30 2016-11-16 The Board Of Trustees Of The Leland Stanford Junior University Aav capsid proteins
WO2010005533A2 (en) 2008-06-30 2010-01-14 The Johns Hopkins University Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
WO2010099383A2 (en) 2009-02-26 2010-09-02 The Johns Hopkins University Compositions and methods for ex vivo hepatic nucleic acid delivery
US20120172419A1 (en) 2009-09-15 2012-07-05 Medical College Of Wisconsin Research Foundation Inc. Reagents and methods for modulating cone photoreceptor activity
SG10201502270TA (en) 2010-03-29 2015-05-28 Univ Pennsylvania Pharmacologically induced transgene ablation system
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
EP2661494B1 (en) 2011-01-07 2019-06-12 Applied Genetic Technologies Corporation Promoters, expression cassettes and vectors for use treating achromatopsia and other diseases
GB201103062D0 (en) 2011-02-22 2011-04-06 Isis Innovation Method
WO2012158757A1 (en) 2011-05-16 2012-11-22 The Trustees Of The University Of Pennsylvania Proviral plasmids for production of recombinant adeno-associated virus
US9375491B2 (en) 2011-10-28 2016-06-28 University Of Florida Research Foundation, Inc. Chimeric promoter for cone photoreceptor targeted gene therapy
WO2013086515A1 (en) 2011-12-09 2013-06-13 The Johns Hopkins University Compositions and methods for the prevention or treatment of diabetic complications
DE18200782T1 (de) 2012-04-02 2021-10-21 Modernatx, Inc. Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
CA2878171C (en) 2012-07-11 2021-04-27 The Trustees Of The University Of Pennsylvania Aav-mediated gene therapy for rpgr x-linked retinal degeneration
US9567376B2 (en) 2013-02-08 2017-02-14 The Trustees Of The University Of Pennsylvania Enhanced AAV-mediated gene transfer for retinal therapies
US10494645B2 (en) 2013-04-18 2019-12-03 Fondazione Telethon Effective delivery of large genes by dual AAV vectors
EP3517135B1 (en) 2013-05-16 2025-11-19 Beacon Therapeutics (USA), Inc. Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
GB201322798D0 (en) 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
KR102288849B1 (ko) * 2014-03-17 2021-08-12 애드베룸 바이오테크놀로지스, 인코포레이티드 원추세포에서 증강된 유전자 발현을 위한 조성물 및 방법
JP6635942B2 (ja) 2014-04-15 2020-01-29 アプライド ジェネティック テクノロジーズ コーポレイション 網膜色素変性症gtpアーゼレギュレーター(rpgr)をコードするコドン最適化核酸
US20160206704A1 (en) 2015-01-16 2016-07-21 Isis Innovation Limited Method
EP3389724B1 (en) 2015-12-14 2020-07-01 The Trustees Of The University Of Pennsylvania Gene therapy for ocular disorders
EP3638316A4 (en) * 2017-06-14 2021-03-24 The Trustees Of The University Of Pennsylvania GENE THERAPY FOR EYE DISEASES

Similar Documents

Publication Publication Date Title
JP2020527335A5 (enExample)
JP7303287B2 (ja) 新規アデノ随伴ウイルスキャプシドタンパク質
JP2019502378A5 (enExample)
RU2018125468A (ru) Генная терапия офтальмологических нарушений
JP2019521696A5 (enExample)
JP2020528734A5 (enExample)
JP2020522269A5 (enExample)
CN115298316A (zh) 用于制备腺相关病毒载体的方法
EP2524037A1 (en) Restrictive inverted terminal repeats for viral vectors
JP2021522842A (ja) 肝臓を標的とするアデノ随伴ウイルスベクター
JP2018108113A5 (enExample)
AU2019250249A1 (en) Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
JP2017509632A5 (enExample)
WO2012158757A1 (en) Proviral plasmids for production of recombinant adeno-associated virus
US20230159953A1 (en) Closed-ended, linear, duplex adenoassociated virus dna, and uses thereof
JP7530431B2 (ja) Dna増幅方法
JP7586547B2 (ja) 昆虫細胞内で重複オープンリーディングフレームを含む遺伝子を発現するための発現カセット及びその使用
JP2017529395A5 (enExample)
AU2021456513B2 (en) Expression cassette of gene comprising overlapping open reading frames and application thereof in insect cell
CN116419974A (zh) 重组aav的制备方法
JP2024517104A (ja) Careエレメントを用いたdna増幅方法
RU2019130004A (ru) Генная терапия при глазных заболеваниях
JP2020510433A5 (enExample)
JP2018536432A5 (enExample)
JP2025534369A (ja) 3種の異なるヘルパーウイルス由来のヘルパーエレメントを含むキメラヘルパー核酸分子